Notably, this germline-driven convergence onto FOXA1/AR pathways parallels the well-established somatic mutations that also funnel into AR-regulated networks, underscoring a shared molecular axis of prostate cancer pathogenesis. This evidence concerns the gene FOXA1 and prostate carcinoma.